Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.

A. Brahme (Pune, India), S. Kadam (Pune, India), M. Agrawal (Pune, India), K. Apte (Pune, India), G. Narke (Pune, India), S. Madas (Pune, India), S. Salvi (Pune, India), A. Agarwal (Pune, India)

Source: International Congress 2018 – Functional genomics and COPD: new challenges
Session: Functional genomics and COPD: new challenges
Session type: Thematic Poster
Number: 934
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Brahme (Pune, India), S. Kadam (Pune, India), M. Agrawal (Pune, India), K. Apte (Pune, India), G. Narke (Pune, India), S. Madas (Pune, India), S. Salvi (Pune, India), A. Agarwal (Pune, India). Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.. 934

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020